申请人:BIAL-PORTELA & Cª, S.A.
公开号:US20160166560A1
公开(公告)日:2016-06-16
A compound having Formula I:
wherein: R1 is selected from hydrogen, halogen, hydroxyl and C
1-4
alkoxy; R2 is selected from hydrogen, halogen, hydroxyl and C
1-4
alkoxy; R3 is C
1-4
alkyl; R4 is aryl which is substituted with a group selected from OSO
2
NH
2
, NHCONH
2
, NHSO
2
NH
2
, NHSO
2
C
1-4
alkyl and CONH
2
; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that the compound is not N-(1-benzylpiperidin-4-yl)-N-methyl-4-(4-(sulfamoylamino)phenyl)-1H-imidazole-1-carboxamide or N-(1-benzylpiperidin-4-yl)-N-methyl-4-(3-(methyl sulfonamido)phenyl)-1H-imidazole-1-carboxamide. The compound may be used as an inhibitor of fatty acid amide hydrolase.
化合物I的化学式为:其中:R1选择自氢、卤素、羟基和C1-4烷氧基;R2选择自氢、卤素、羟基和C1-4烷氧基;R3为C1-4烷基;R4为芳基,其被选择自OSO2NH2、NHCONH2、NHSO2NH2、NHSO2C1-4烷基和CONH2的基团取代;n为0或1;或其药学上可接受的盐;但化合物不是N-(1-苄基哌啶-4-基)-N-甲基-4-(4-(磺酰胺基)苯基)-1H-咪唑-1-羧酰胺或N-(1-苄基哌啶-4-基)-N-甲基-4-(3-(甲基磺酰氨基)苯基)-1H-咪唑-1-羧酰胺。该化合物可用作脂肪酸酰胺水解酶的抑制剂。